Gillespie, D <br/><br/>
Synergistic inhibition of AZT-resistant HIV by AZT combined with poly(I):poly(C12U), without synergistic toxicity to bone marrow progenitor cell elements.  [electronic resource] 

 -  In vivo (Athens, Greece)   
 - 375-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0258-851X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--adverse effects<br/>Colony-Forming Units Assay<br/>Drug Resistance<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>HIV--drug effects<br/>HIV Infections--drug therapy<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Poly I-C--adverse effects<br/>Poly U--adverse effects<br/>RNA, Double-Stranded<br/>Zidovudine--adverse effects